Redeye: Isofol Medical - Knowledge is Power
Today we initiate coverage of biotech company Isofol Medical, that developing Modufolin, a new therapy used in the treatment of colorectal cancer and as a rescue therapy after high-dose chemotherapy treatment.
Continue reading at: https://goo.gl/YgXjvT
Start following companies at Redeye to receive the latest equity research within Life Science and Technology.
This is a press release from Redeye - Research Powered Investment Banking. https://www.redeye.se